NASDAQ:SLS | Free Cash Flow | SELLAS Life Sciences Group, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$8.85M
2025-12-31-$4.92M
2025-03-31-$9.07M
2024-12-31-$7.15M
2024-03-31-$10.76M
2023-12-31-$4.83M
2023-03-31-$12.13M
2022-12-31-$5.15M
2022-03-31-$7.15M
2021-12-31-$4.98M
2021-03-31-$10.27M
2020-12-31$3.42M
2020-03-31-$6.83M
2019-12-31-$4.18M
2019-03-31-$4.99M
2018-12-31-$4.56M
2018-03-31-$5.4M
2017-12-31-$1.74M
2017-03-31-$3.8M
2016-12-31$25.07M$0.00$25.07M7120.74%
2016-03-31-$13.22M$6,000.00-$13.22M
2015-12-31-$15.28M$72,000.00-$15.36M
2015-03-31-$11.56M$18,000.00-$11.57M
2014-12-31-$10.73M$9,000.00-$10.74M
2014-03-31-$8.05M$22,000.00-$8.07M
2013-12-31-$8.49M-$234,000.00-$8.73M
2013-03-31-$5.33M
2012-12-31-$5.18M
2012-03-31-$4.89M
2011-12-31-$4.17M$0.00-$4.17M-262.37%
2011-03-31-$3.03M$40,000.00-$3.07M
2010-12-31-$1.87M$41,000.00-$1.91M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$28.39M
2024-12-31-$35.4M
2023-12-31-$31.41M
2022-12-31-$23.81M
2021-12-31-$26.02M
2020-12-31-$10.42M
2019-12-31-$17.64M
2018-12-31-$30.42M
2017-12-31-$10.99M
2016-12-31-$11.85M$6,000.00-$11.86M
2015-12-31-$48.16M$153,000.00-$48.31M
2014-12-31-$42.87M$57,000.00-$42.93M
2013-12-31-$28.93M$320,000.00-$29.25M
2012-12-31-$20.97M
2011-12-31-$14.67M$53,000.00-$14.72M
2010-12-31-$10.26M$106,000.00-$10.36M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.